Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
4(40%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
10%
Ph not_applicable
9
90%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

10

all time

Status Distribution
Active(4)
Completed(6)

Detailed Status

Completed6
Recruiting3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (10.0%)
N/A9 (90.0%)

Trials by Status

completed660%
recruiting330%
active_not_recruiting110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
10